The Evolution of Multimodality Therapy for Malignant Pleural Mesothelioma
β Scribed by Marjorie G. Zauderer; Lee M. Krug
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 146 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1527-2729
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A total of 31 patients with malignant pleural mesothelioma disease, limited to one hemithorax, were entered into a phase II study of surgery and intracavitary photodynamic therapy. PhotofrinrΜ, 2 mg/kg, was injected intravenously, and 48 hours later the patient was taken to the operatin
## Abstract ## Background and Objectives Experimental assessment of photodynamic therapy (PDT) for malignant pleural mesothelioma using a polyethylene glycol conjugate of __meta__βtetrahydroxyphenylchlorin (PEGβ__m__THPC). ## Study Design/Materials and Methods (a) PDT was tested on Hβmesoβ1 xeno